NCT05010005 2025-12-03A Study of Ruxolitinib and Duvelisib in People With LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting70 enrolled
NCT06810778 2025-07-15Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Jonsson Comprehensive Cancer CenterPhase 1/2 Recruiting12 enrolled